Larimar Therapeutics (LRMR) Return on Capital Employed [ROCE] (2014 - 2026)
Larimar Therapeutics' Return on Capital Employed [ROCE] came in at -144.69% for Q2 2026, down 63.35 percentage points from -81.34% a year earlier.
Larimar Therapeutics (LRMR) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Larimar Therapeutics' Return on Capital Employed [ROCE] was -159.37%, down 85.91 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined in each of the last three years, with a five-year change of -66.22 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -73.46% in FY2024 (-32.39 pp), -41.07% in FY2023 (-1.30 pp), -39.78% in FY2022 (+21.15 pp) and -60.93% in FY2021 (+32.22 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -169.45% (Q4 2025) to -29.72% (Q2 2024).
- Year-over-year, Return on Capital Employed [ROCE] increased in 1 of the last seven quarters, with an average year-over-year change of -49.50 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2023 (a gain of 40.74 percentage points), and the weakest in Q4 2025 (a drop of 120.39 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Larimar Therapeutics | 317.88 Mn | -289.20 Mn | - | -144.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -144.69% |
| Dec 31, 2025 | -169.45% |
| Sep 30, 2025 | -113.13% |
| Jun 30, 2025 | -81.34% |
| Mar 31, 2025 | -64.60% |
| Dec 31, 2024 | -49.06% |
| Sep 30, 2024 | -34.82% |
| Jun 30, 2024 | -29.72% |
| Mar 31, 2024 | -31.94% |
| Dec 31, 2023 | -46.17% |
| Sep 30, 2023 | -37.56% |
| Jun 30, 2023 | -33.52% |
| Mar 31, 2023 | -30.77% |
| Dec 31, 2022 | -30.69% |
| Sep 30, 2022 | -39.74% |
| Jun 30, 2022 | -73.15% |
| Mar 31, 2022 | -71.51% |
| Dec 31, 2021 | -67.78% |
| Sep 30, 2021 | -75.24% |
| Jun 30, 2021 | -62.28% |
Larimar Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();